Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone

Gan,Lang; Pan,Shuguang; Cui,Jinchi; Bai,Jie; Jiang,Peng; He,Yu

doi:10.3892/mmr.2018.9661

Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone

Authors:
- Lang Gan
- Shuguang Pan
- Jinchi Cui
- Jie Bai
- Peng Jiang
- Yu He
View Affiliations

Affiliations: Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, P.R. China
Published online on: November 15, 2018 https://doi.org/10.3892/mmr.2018.9661
Pages: 195-204
Copyright: © Gan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The adenosine 5'‑triphosphate binding cassette subfamily B member (ABCB)11 gene is involved in bile transport, and mutations in this gene are associated with cholestasis and cholelithiasis. Therefore, the aim of the present study was to investigate the association between ABCB11 gene mutation and primary intrahepatic stone (PIS)s and to investigate the mechanism through which ABCB11 gene mutations affect the expression of the corresponding protein. Mutations of the ABCB11 gene in 443 PIS patients and 560 healthy participants were detected by exon sequencing. The expression levels of ABCB11 mRNA and bile salt export pump (BSEP) protein in the liver tissues of patients with PISs were measured by quantitative polymerase chain reaction and western blot analysis. The mutant plasmids constructed by site‑directed mutagenesis of the human BSEP gene were transfected into human embryonic kidney 293 (293) cells and Madin‑Darby canine kidney (MDCK) cells, and the expression and distribution of rs118109635 of BSEP was measured. There were two significant mutations in the ABCB11 gene of the PIS patients compared with the healthy population; a missense mutation, rs118109635 (P=0.025), and a synonymous mutation, rs497692 (P=0.006). The two mutations were associated with the occurrence of preoperative jaundice (P=0.026, and P=0.011, respectively). The expression levels of BSEP in PIS patients with the missense mutation rs118109635 was decreased, whereas its mRNA expression levels remained unchanged. In PIS patients with the synonymous mutation rs497692, the expression levels of ABCB11 were decreased at both the mRNA and protein level. It was also found that mutation A865V reduced the expression levels of BSEP in 293 cells at the cellular level; its distribution in MDCK cell membranes was decreased, whereas its mRNA levels remained unchanged. The mutated loci at rs118109635 and rs497692 of the ABCB11 gene were correlated with PISs, causing a decreased expression of BSEP and reduced distribution of the protein in the cell membrane. Therefore, mutations at rs118109635 and rs497692 of the ABCB11 gene may be risk factors for PISs.

View Figures

View References

1	Clemente G, De Rose AM, Murri R, Ardito F, Nuzzo G and Giuliante F: Liver resection for primary intrahepatic stones: Focus on postoperative infectious complications. World J Surg. 40:433–439. 2016. View Article : Google Scholar : PubMed/NCBI
2	Li SQ, Hua YP, Shen SL, Hu WJ, Peng BG and Liang LJ: Segmental bile duct-targeted liver resection for right-sided intrahepatic stones. Medicine (Baltimore). 94:e11582015. View Article : Google Scholar : PubMed/NCBI
3	Catena M, Aldrighetti L, Finazzi R, Arzu G, Arru M, Pulitanò C and Ferla G: Treatment of non-endemic hepatolithiasis in a Western country. The role of hepatic resection. Ann R Coll Surg Engl. 88:383–389. 2006. View Article : Google Scholar : PubMed/NCBI
4	Nakayama F, Soloway RD, Nakama T, Miyazaki K, Ichimiya H, Sheen PC, Ker CG, Ong GB, Choi TK, Boey J, et al: Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci. 31:21–26. 1986. View Article : Google Scholar : PubMed/NCBI
5	Pan S, Li X, Jiang P, Jiang Y, Shuai L, He Y and Li Z: Variations of ABCB4 and ABCB11 genes are associated with primary intrahepatic stones. Mol Med Rep. 11:434–446. 2015. View Article : Google Scholar : PubMed/NCBI
6	Meng ZW, Han SH, Zhu JH, Zhou LY and Chen YL: Risk factors for cholangiocarcinoma after initial hepatectomy for intrahepatic stones. World J Surg. 41:835–843. 2017. View Article : Google Scholar : PubMed/NCBI
7	Cetta FM: Bile infection documented as initial event in the pathogenesis of brown pigment biliary stones. Hepatology. 6:482–489. 1986. View Article : Google Scholar : PubMed/NCBI
8	Sakpal SV, Babel N and Chamberlain RS: Surgical management of hepatolithiasis. HPB (Oxford). 11:194–202. 2009. View Article : Google Scholar : PubMed/NCBI
9	Tazuma S: Gallstone disease: Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic). Best Pract Res Clin Gastroenterol. 20:1075–1083. 2006. View Article : Google Scholar : PubMed/NCBI
10	Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, Nussler N, Eichelbaum M, Meier PJ and Stieger B: Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology. 44:62–74. 2006. View Article : Google Scholar : PubMed/NCBI
11	Kubitz R, Dröge C, Kluge S, Stindt J and Häussinger D: Genetic variations of bile salt transporters. Drug Discov Today Technol. 12:e55–e67. 2014. View Article : Google Scholar : PubMed/NCBI
12	Kubitz R, Dröge C, Stindt J, Weissenberger K and Häussinger D: The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol. 36:536–553. 2012. View Article : Google Scholar : PubMed/NCBI
13	Chen R, Wang J, Tang S, Zhang Y, Lv X, Wu S, Yang Z, Xia Y, Chen D and Zhan S: Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort. Sci Rep. 6:277502016. View Article : Google Scholar : PubMed/NCBI
14	Chai J, He Y, Cai SY, Jiang Z, Wang H, Li Q, Chen L, Peng Z, He X, Wu X, et al: Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase-signaling pathway. Hepatology. 55:1485–1494. 2012. View Article : Google Scholar : PubMed/NCBI
15	Beausejour Y, Alvarez F, Beaulieu M and Bilodeau M: Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family. Can J Gastroenterol. 25:311–314. 2011. View Article : Google Scholar : PubMed/NCBI
16	Hayashi H, Naoi S, Hirose Y, Matsuzaka Y, Tanikawa K, Igarashi K, Nagasaka H, Kage M, Inui A and Kusuhara H: Successful treatment with 4-phenylbutyrate in a patient with benign recurrent intrahepatic cholestasis type 2 refractory to biliary drainage and bilirubin absorption. Hepatol Res. 46:192–200. 2016. View Article : Google Scholar : PubMed/NCBI
17	Hayashi H, Takada T, Suzuki H, Akita H and Sugiyama Y: Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11. Hepatology. 41:916–924. 2005. View Article : Google Scholar : PubMed/NCBI
18	Waisbourd-Zinman O, Surrey LF, Schwartz AE, Russo PA and Wen J: A Rare BSEP mutation associated with a mild form of progressive familial intrahepatic cholestasis type 2. Ann Hepatol. 16:465–468. 2017. View Article : Google Scholar : PubMed/NCBI
19	Keitel V, Burdelski M, Warskulat U, Kühlkamp T, Keppler D, Häussinger D and Kubitz R: Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology. 41:1160–1172. 2005. View Article : Google Scholar : PubMed/NCBI
20	Anzivino C, Odoardi MR, Meschiari E, Baldelli E, Facchinetti F, Neri I, Ruggiero G, Zampino R, Bertolotti M, Loria P and Carulli L: ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population. Dig Liver Dis. 45:226–232. 2013. View Article : Google Scholar : PubMed/NCBI
21	Keitel V, Vogt C, Häussinger D and Kubitz R: Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy. Gastroenterology. 131:624–629. 2006. View Article : Google Scholar : PubMed/NCBI
22	Lim TY, Coltart I, Foskett P, Thompson R, Strautnieks S, Penna L, Williamson C, Miquel R and Heneghan MA: Donor transmitted mutation of the ABCB11 gene and ensuing intrahepatic cholestasis of pregnancy in a liver transplant recipient. Liver Transpl. 23:1229–1232. 2017. View Article : Google Scholar : PubMed/NCBI
23	Lam P, Pearson CL, Soroka CJ, Xu S, Mennone A and Boyer JL: Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases. Am J Physiol Cell Physiol. 293:C1709–C1716. 2007. View Article : Google Scholar : PubMed/NCBI
24	Li Z, Chen K, Jiang P, Zhang X, Li X and Li Z: CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Diagn Pathol. 9:792014. View Article : Google Scholar : PubMed/NCBI
25	Gordo-Gilart R, Andueza S, Hierro L, Martínez-Fernández P, D'Agostino D, Jara P and Alvarez L: Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity. Gut. 64:147–155. 2015. View Article : Google Scholar : PubMed/NCBI
26	Wang R, Chen HL, Liu L, Sheps JA, Phillips MJ and Ling V: Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump. Hepatology. 50:948–956. 2009. View Article : Google Scholar : PubMed/NCBI
27	Hu G, He P, Liu Z, Chen Q, Zheng B and Zhang Q: Diagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing. Mol Med Rep. 10:1264–1274. 2014. View Article : Google Scholar : PubMed/NCBI
28	Park JS, Ko JS, Seo JK, Moon JS and Park SS: Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis. World J Gastroenterol. 22:4901–4907. 2016. View Article : Google Scholar : PubMed/NCBI
29	Tai Y, Xie Y and Tang CW: Compound heterozygous mutations of ABCB11 responsible for benign recurrent intrahepatic cholestasis. J Dig Dis. 16:299–302. 2015. View Article : Google Scholar : PubMed/NCBI
30	Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, Mieli-Vergani G and Thompson RJ: Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology. 49:553–567. 2009. View Article : Google Scholar : PubMed/NCBI
31	Hayashi H and Sugiyama Y: 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps. Hepatology. 45:1506–1516. 2007. View Article : Google Scholar : PubMed/NCBI